Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
P22760
UPID:
AAAD_HUMAN
Alternative names:
-
Alternative UPACC:
P22760; A8K3L3; D3DNJ6; Q8N1A9
Background:
Arylacetamide deacetylase, identified by the accession number P22760, plays a crucial role in metabolic processes within the liver. It exhibits cellular triglyceride lipase activity, contributing to the hydrolysis of triglycerides into fatty acids, essential for very low-density lipoprotein assembly. Additionally, it possesses serine esterase activity and is involved in the deacetylation of arylacetamide substrates, including xenobiotic compounds and procarcinogens, thereby increasing their toxicity.
Therapeutic significance:
Understanding the role of Arylacetamide deacetylase could open doors to potential therapeutic strategies. Its involvement in lipid metabolism and detoxification processes makes it a promising target for addressing liver diseases and managing the effects of xenobiotic compounds.